Clinuvel Pharmaceuticals Ltd
F:UR9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Clinuvel Pharmaceuticals Ltd
F:UR9
|
AU |
|
Storytel AB (publ)
F:DST
|
SE |
|
C
|
CNOOC Ltd
F:NC2A
|
CN |
|
CTO Realty Growth Inc
F:8QB0
|
US |
|
C
|
Capital & Counties Properties PLC
XBER:C20
|
UK |
|
F
|
FinanzaTech SpA SB
MIL:FTC
|
IT |
|
Exel Composites Oyj
F:8TY
|
FI |
|
G
|
Gazprom Neft' PAO
F:SCF
|
RU |
|
Bel Fuse Inc
F:BF2A
|
US |
|
Creative Technology Ltd
F:CTL
|
SG |
|
Target Hospitality Corp
NASDAQ:TH
|
US |
|
M
|
Minerva Neurosciences Inc
F:4MN
|
US |
|
L
|
Lloyds Banking Group PLC
OTC:LLDTF
|
UK |
|
H
|
Hacksaw AB
STO:HACK
|
SE |
|
T
|
TD Synnex Corp
F:SUX
|
US |
|
L
|
Lloyds Banking Group PLC
XMUN:LLD
|
UK |
|
H
|
Huron Consulting Group Inc
F:HUR
|
US |
|
A
|
AMP Ltd
F:AMP
|
AU |
|
Professional Diversity Network Inc
NASDAQ:IPDN
|
US |
|
C
|
ConvaTec Group PLC
F:2CV
|
UK |
|
Bird Construction Inc
F:6LT
|
CA |
|
L
|
LXP Industrial Trust
F:LXN
|
US |
|
A
|
A G Barr PLC
F:AF72
|
UK |
Wall St Price Targets
UR9 Price Targets Summary
Clinuvel Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for UR9 is 16.51 EUR with a low forecast of 8.84 EUR and a high forecast of 27.7 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UR9's stock price target?
Price Target
16.51
EUR
According to Wall Street analysts, the average 1-year price target for UR9 is 16.51 EUR with a low forecast of 8.84 EUR and a high forecast of 27.7 EUR.
What is the Revenue forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 39%. The projected CAGR for the next 8 years is 7%.
What is the Operating Income forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
9%
The compound annual growth rate for Operating Income over the next 8 years is 9%.
What is the Net Income forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
10%
The compound annual growth rate for Net Income over the next 8 years is 10%.
